News Daily News MOSAIC: Home Intervention Boosts Walking Time in PAD Patients L.A. McKeown April 15, 2022
News Conference News ACC 2022 Second-Generation Chocolate Touch DCB Bests Lutonix for Patency in PAD L.A. McKeown April 04, 2022
News Conference News ACC 2022 PROMPT-HF: Pop-up Alerts Improve HFrEF Medication Optimization L.A. McKeown April 03, 2022
News Daily News Diet Drinks May Help With Weight Loss and Cardiometabolic Control L.A. McKeown March 17, 2022
News Daily News Postmarketing Studies of CV Devices Still Lacking in the US Caitlin E. Cox March 17, 2022
News Daily News Routine IVUS in Peripheral Interventions Supported by Small RCT L.A. McKeown March 09, 2022
News Daily News VISION Eyeballs Too-Low Troponin Values for MI, Injury After Cardiac Surgery L.A. McKeown March 04, 2022
News Daily News Fewer Diabetic Complications Seen When NOACs Given for AF L.A. McKeown February 22, 2022
News Daily News ROOBY-FS: 10-Year Data Affirm On-Pump CABG as Default Strategy L.A. McKeown February 18, 2022
News Daily News Chinese Herbal Formula Matches Losartan in Patients With Mild Hypertension Caitlin E. Cox February 11, 2022
News Conference News ISC 2022 Endovascular Stroke Therapy Works for Large Infarcts: RESCUE-Japan LIMIT Todd Neale February 09, 2022
News Daily News USPSTF: Data Around Screening for AF in Asymptomatic Adults Still Lacking Todd Neale January 25, 2022
News Daily News Differing Advice for Infective Endocarditis Surgery Stems From Evidence Gaps Caitlin E. Cox January 25, 2022
News Industry News IMPRESSION Randomized Trial: Past the halfway mark and progressing rapidly January 22, 2022
News Daily News DOACs Should Be Standard to Prevent VTE Recurrence in Cancer: Meta-analysis L.A. McKeown January 20, 2022
News Features Pricey Inclisiran Is Rolling Out: a ‘Buy-and-Bill’ Model May Smooth Its Path Michael O'Riordan January 17, 2022
News Daily News Shorter Anticoagulation an Option for Young Patients With Provoked VTE Todd Neale January 11, 2022
News Daily News TCTMD’s Top 10 Most Popular Stories for December 2021 Caitlin E. Cox December 29, 2021
News Daily News Apixaban Appears Safer, More Effective Than Rivaroxaban in Medicare Study Todd Neale December 27, 2021